目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. End-use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. End-use outlook
2.2.3. Regional outlook
2.3. Competitive Insights

Chapter 3. Neurothrombectomy Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing prevalence of acute ischemic strokes
3.4.1.2. Introduction of technologically advanced products
3.4.1.3. Rising Adoption of unhealthy lifestyle
3.4.2. Market restraint analysis
3.4.2.1. Stringent and complex regulatory framework
3.4.2.2. Risks associated with the neurothrombectomy devices
3.5. Neurothrombectomy Devices Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. The threat of new entrants
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies

Chapter 4. Neurothrombectomy Devices Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Clot Retrievers
4.1.2. Aspiration/Suction Devices
4.1.3. Vascular Snares
4.2. Type Market Share, 2022 & 2030
4.3. Segment Dashboard
4.4. Neurothrombectomy Devices Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Clot Retrievers
4.5.1.1. Clot Retrievers market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Aspiration/Suction Devices
4.5.2.1. Aspiration/Suction Devices market estimates and forecast 2018 to 2030 (USD Million)
4.5.3 Vascular Snares
4.5.3.1 Vascular Snares market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Neurothrombectomy Devices Market: End-use Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Hospital
5.1.2. Emergency Clinics
5.1.3. Ambulatory Surgical Centers
5.2. End-use Market Share, 2022 & 2030
5.3. Segment Dashboard
5.4. Neurothrombectomy Devices Market by End-use Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Hospital
5.5.1.1. Hospital market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Emergency Clinics
5.5.2.1. Emergency Clinics market estimates and forecast 2018 to 2030 (USD Million)
5.5.3. Ambulatory Surgical Centers
5.5.3.1. Ambulatory Surgical Centers market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Neurothrombectomy Devices Market: Regional Estimates & Trend Analysis
6.1. Regional market share analysis, 2022 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Regional Market Share and Leading Players, 2022
6.4.1. North America
6.4.2. Europe
6.4.3. Asia Pacific
6.4.4. Latin America
6.4.5. Middle East and Africa
6.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030
6.6. North America
6.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.6.2. U.S.
6.6.2.1. Key country dynamics
6.6.2.2. Competitive scenario
6.6.2.3. Regulatory framework
6.6.2.4. Reimbursement scenario
6.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
6.6.3. Canada
6.6.3.1. Key country dynamics
6.6.3.2. Competitive scenario
6.6.3.3. Regulatory framework
6.6.3.4. Reimbursement scenario
6.6.3.5. Canada market estimates and forecasts, 2018 - 2030
6.7. Europe
6.7.1. UK
6.7.1.1. Key country dynamics
6.7.1.2. Competitive scenario
6.7.1.3. Regulatory framework
6.7.1.4. Reimbursement scenario
6.7.1.5. UK market estimates and forecasts, 2018 - 2030
6.7.2. Germany
6.7.2.1. Key country dynamics
6.7.2.2. Competitive scenario
6.7.2.3. Regulatory framework
6.7.2.4. Reimbursement scenario
6.7.2.5. Germany market estimates and forecasts, 2018 - 2030
6.7.3. France
6.7.3.1. Key country dynamics
6.7.3.2. Competitive scenario
6.7.3.3. Regulatory framework
6.7.3.4. Reimbursement scenario
6.7.3.5. France market estimates and forecasts, 2018 - 2030
6.7.4. Italy
6.7.4.1. Key country dynamics
6.7.4.2. Competitive scenario
6.7.4.3. Regulatory framework
6.7.4.4. Reimbursement scenario
6.7.4.5. Italy market estimates and forecasts, 2018 - 2030
6.7.5. Spain
6.7.5.1. Key country dynamics
6.7.5.2. Competitive scenario
6.7.5.3. Regulatory framework
6.7.5.4. Reimbursement scenario
6.7.5.5. Spain market estimates and forecasts, 2018 - 2030
6.7.6. Denmark
6.7.6.1. Key country dynamics
6.7.6.2. Competitive scenario
6.7.6.3. Regulatory framework
6.7.6.4. Reimbursement scenario
6.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
6.7.7. Sweden
6.7.7.1. Key country dynamics
6.7.7.2. Competitive scenario
6.7.7.3. Regulatory framework
6.7.7.4. Reimbursement scenario
6.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
6.7.8. Norway
6.7.8.1. Key country dynamics
6.7.8.2. Competitive scenario
6.7.8.3. Regulatory framework
6.7.8.4. Reimbursement scenario
6.7.8.5. Norway market estimates and forecasts, 2018 - 2030
6.8. Asia Pacific
6.8.1. Japan
6.8.1.1. Key country dynamics
6.8.1.2. Competitive scenario
6.8.1.3. Regulatory framework
6.8.1.4. Reimbursement scenario
6.8.1.5. Japan market estimates and forecasts, 2018 - 2030
6.8.2. India
6.8.2.1. Key country dynamics
6.8.2.2. Competitive scenario
6.8.2.3. Regulatory framework
6.8.2.4. Reimbursement scenario
6.8.2.5. India market estimates and forecasts, 2018 - 2030
6.8.3. China
6.8.3.1. Key country dynamics
6.8.3.2. Competitive scenario
6.8.3.3. Regulatory framework
6.8.3.4. Reimbursement scenario
6.8.3.5. China market estimates and forecasts, 2018 - 2030
6.8.4. South Korea
6.8.4.1. Key country dynamics
6.8.4.2. Competitive scenario
6.8.4.3. Regulatory framework
6.8.4.4. Reimbursement scenario
6.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
6.8.5. Australia
6.8.5.1. Key country dynamics
6.8.5.2. Competitive scenario
6.8.5.3. Regulatory framework
6.8.5.4. Reimbursement scenario
6.8.5.5. Australia market estimates and forecasts, 2018 - 2030
6.8.6. Thailand
6.8.6.1. Key country dynamics
6.8.6.2. Competitive scenario
6.8.6.3. Regulatory framework
6.8.6.4. Reimbursement scenario
6.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
6.9. Latin America
6.9.1. Brazil
6.9.1.1. Key country dynamics
6.9.1.2. Competitive scenario
6.9.1.3. Regulatory framework
6.9.1.4. Reimbursement scenario
6.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
6.9.2. Mexico
6.9.2.1. Key country dynamics
6.9.2.2. Competitive scenario
6.9.2.3. Regulatory framework
6.9.2.4. Reimbursement scenario
6.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
6.9.3. Argentina
6.9.3.1. Key country dynamics
6.9.3.2. Competitive scenario
6.9.3.3. Regulatory framework
6.9.3.4. Reimbursement scenario
6.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
6.10. MEA
6.10.1. South Africa
6.10.1.1. Key country dynamics
6.10.1.2. Competitive scenario
6.10.1.3. Regulatory framework
6.10.1.4. Reimbursement scenario
6.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
6.10.2. Saudi Arabia
6.10.2.1. Key country dynamics
6.10.2.2. Competitive scenario
6.10.2.3. Regulatory framework
6.10.2.4. Reimbursement scenario
6.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
6.10.3. UAE
6.10.3.1. Key country dynamics
6.10.3.2. Competitive scenario
6.10.3.3. Regulatory framework
6.10.3.4. Reimbursement scenario
6.10.3.5. UAE market estimates and forecasts, 2018 - 2030
6.10.4. Kuwait
6.10.4.1. Key country dynamics
6.10.4.2. Competitive scenario
6.10.4.3. Regulatory framework
6.10.4.4. Reimbursement scenario
6.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.2.1. Innovators
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2022
7.3.4. Medtronic
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Acandis GmbH
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Phenox GmbH
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Stryker
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Penumbra, Inc.
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Vesalio
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives

List of Tables
Table 1 List of Abbreviation
Table 2 North America neurothrombectomy devices market, by Region, 2018 - 2030 (USD Million)
Table 3 North America neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 4 North America neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 5 U.S. neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 6 U.S. neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 7 Canada neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 8 Canada neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 9 Europe neurothrombectomy devices market, by region, 2018 - 2030 (USD Million)
Table 10 Europe neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 11 Europe neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 12 UK neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 13 UK neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 14 Germany neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 15 Germany neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 16 France neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 17 France neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 18 Italy neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 19 Italy neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 20 Spain neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 21 Spain neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 22 Denmark neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 23 Denmark neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 24 Sweden neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 25 Sweden neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 26 Norway neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 27 Norway neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 28 Asia Pacific neurothrombectomy devices market, by region, 2018 - 2030 (USD Million)
Table 29 Asia Pacific neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 30 Asia Pacific neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 31 Japan neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 32 Japan neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 33 China neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 34 China neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 35 India neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 36 India neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 37 Australia neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 38 Australia neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 39 Thailand neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 40 Thailand neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 41 South Korea neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 42 South Korea neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 43 Latin America neurothrombectomy devices market, by region, 2018 - 2030 (USD Million)
Table 44 Latin America neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 45 Latin America neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 46 Brazil neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 47 Brazil neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 48 Mexico neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 49 Mexico neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 50 Argentina neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 51 Argentina neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 52 Middle East and Africa neurothrombectomy devices market, by region, 2018 - 2030 (USD Million)
Table 53 Middle East and Africa neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 54 Middle East and Africa neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 55 South Africa neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 56 South Africa neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 59 UAE neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 60 UAE neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
Table 61 Kuwait neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
Table 62 Kuwait neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value - chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Neurothrombectomy devices market: market outlook
Fig. 14 Neurothrombectomy devices market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Neurothrombectomy devices market driver impact
Fig. 20 Neurothrombectomy devices market restraint impact
Fig. 21 Neurothrombectomy devices market strategic initiatives analysis
Fig. 22 Neurothrombectomy devices market: product movement analysis
Fig. 23 Neurothrombectomy devices market: product outlook and key takeaways
Fig. 24 Clot retrievers market estimates and forecast, 2018 - 2030
Fig. 25 Aspiration/Suction devices market estimates and forecast, 2018 - 2030
Fig. 26 Vascular Snares market estimates and forecast, 2018 - 2030
Fig. 27 Neurothrombectomy devices market: end-use movement analysis
Fig. 28 Neurothrombectomy devices market: end-use outlook and key takeaways
Fig. 29 Hospital market estimates and forecast, 2018 - 2030
Fig. 30 Emergency clinics market estimates and forecast, 2018 - 2030
Fig. 31 Ambulatory surgical centers market estimates and forecast, 2018 - 2030
Fig. 32 Global Neurothrombectomy devices market: Regional movement analysis
Fig. 33 Global Neurothrombectomy devices market: Regional outlook and key takeaways
Fig. 34 Global market shares and leading players
Fig. 35 North America market share and leading players
Fig. 36 Europe market share and leading players
Fig. 37 Asia Pacific market share and leading players
Fig. 38 Latin America market share and leading players
Fig. 39 Middle East & Africa market share and leading players
Fig. 40 North America: SWOT
Fig. 41 Europe SWOT
Fig. 42 Asia Pacific SWOT
Fig. 43 Latin America SWOT
Fig. 44 MEA SWOT
Fig. 45 North America, by country
Fig. 46 North America
Fig. 47 North America market estimates and forecast, 2018 - 2030
Fig. 48 The U.S.
Fig. 49 U.S. market estimates and forecast, 2018 - 2030
Fig. 50 Canada
Fig. 51 Canada market estimates and forecast, 2018 - 2030
Fig. 52 Europe
Fig. 53 Europe market estimates and forecast, 2018 - 2030
Fig. 54 UK
Fig. 55 UK market estimates and forecast, 2018 - 2030
Fig. 56 Germany
Fig. 57 Germany market estimates and forecast, 2018 - 2030
Fig. 58 France
Fig. 59 France market estimates and forecast, 2018 - 2030
Fig. 60 Italy
Fig. 61 Italy market estimates and forecast, 2018 - 2030
Fig. 62 Spain
Fig. 63 Spain market estimates and forecast, 2018 - 2030
Fig. 64 Denmark
Fig. 65 Denmark market estimates and forecast, 2018 - 2030
Fig. 66 Sweden
Fig. 67 Sweden market estimates and forecast, 2018 - 2030
Fig. 68 Norway
Fig. 69 Norway market estimates and forecast, 2018 - 2030
Fig. 70 Asia Pacific
Fig. 71 Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 72 Japan
Fig. 73 Japan market estimates and forecast, 2018 - 2030
Fig. 74 China
Fig. 75 China market estimates and forecast, 2018 - 2030
Fig. 76 India
Fig. 77 India market estimates and forecast, 2018 - 2030
Fig. 78 Australia
Fig. 79 Australia market estimates and forecast, 2018 - 2030
Fig. 80 Thailand
Fig. 81 Thailand market estimates and forecast, 2018 - 2030
Fig. 82 South Korea
Fig. 83 South Korea market estimates and forecast, 2018 - 2030
Fig. 84 Latin America
Fig. 85 Latin America market estimates and forecast, 2018 - 2030
Fig. 86 Brazil
Fig. 87 Brazil market estimates and forecast, 2018 - 2030
Fig. 88 Mexico
Fig. 89 Mexico market estimates and forecast, 2018 - 2030
Fig. 90 Argentina
Fig. 91 Argentina market estimates and forecast, 2018 - 2030
Fig. 92 Middle East and Africa
Fig. 93 Middle East and Africa market estimates and forecast, 2018 - 2030
Fig. 94 Saudi Arabia
Fig. 95 Saudi Arabia market estimates and forecast, 2018 - 2030
Fig. 96 South Africa
Fig. 97 South Africa market estimates and forecast, 2018 - 2030
Fig. 98 UAE
Fig. 99 UAE market estimates and forecast, 2018 - 2030
Fig. 100 Kuwait
Fig. 101 Kuwait market estimates and forecast, 2018 - 2030
Fig. 102 Participant categorization - Neurothrombectomy devices market
Fig. 103 Market share of key market players - Neurothrombectomy devices market